Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DETECT III
2010-024238-46Phase 3Completed
- Sponsor
- University Hospital Ulm
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lapatinib in breast cancer (2 arms), sponsored by University Hospital Ulm. Primary endpoint: Circulating tumor cell clearance rate. Started Sep 2011; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2010-024238-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024238-46.